[go: up one dir, main page]

LU81349A1 - Nouveaux aminothiazoles et composition pharmaceutique les contenant - Google Patents

Nouveaux aminothiazoles et composition pharmaceutique les contenant

Info

Publication number
LU81349A1
LU81349A1 LU81349A LU81349A LU81349A1 LU 81349 A1 LU81349 A1 LU 81349A1 LU 81349 A LU81349 A LU 81349A LU 81349 A LU81349 A LU 81349A LU 81349 A1 LU81349 A1 LU 81349A1
Authority
LU
Luxembourg
Prior art keywords
aminothiazoles
new
pharmaceutical composition
composition containing
pharmaceutical
Prior art date
Application number
LU81349A
Other languages
English (en)
Inventor
J Lombardino
J Bindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of LU81349A1 publication Critical patent/LU81349A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
    • F16B15/00—Nails; Staples
    • F16B15/0023—Nail plates
    • F16B2015/0076—Nail plates with provisions for additional fastening means, e.g. hooks, holes for separate screws or nails, adhesive

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LU81349A 1978-06-02 1979-05-31 Nouveaux aminothiazoles et composition pharmaceutique les contenant LU81349A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US91183078A 1978-06-02 1978-06-02

Publications (1)

Publication Number Publication Date
LU81349A1 true LU81349A1 (fr) 1979-12-07

Family

ID=25430923

Family Applications (1)

Application Number Title Priority Date Filing Date
LU81349A LU81349A1 (fr) 1978-06-02 1979-05-31 Nouveaux aminothiazoles et composition pharmaceutique les contenant

Country Status (36)

Country Link
JP (1) JPS5936988B2 (fr)
AR (1) AR226285A1 (fr)
AT (1) AT373248B (fr)
AU (1) AU511242B2 (fr)
BE (1) BE876732A (fr)
CA (1) CA1117949A (fr)
CH (1) CH639653A5 (fr)
CS (1) CS216927B2 (fr)
DD (1) DD144055A5 (fr)
DE (1) DE2922523C2 (fr)
DK (1) DK150068C (fr)
EG (1) EG14354A (fr)
ES (1) ES481220A1 (fr)
FI (1) FI68820C (fr)
FR (1) FR2427333A1 (fr)
GB (1) GB2022085B (fr)
GR (1) GR73142B (fr)
HK (1) HK66487A (fr)
HU (1) HU180045B (fr)
IE (1) IE48426B1 (fr)
IL (1) IL57450A (fr)
IT (1) IT1121238B (fr)
KE (1) KE3459A (fr)
LU (1) LU81349A1 (fr)
MY (1) MY8500318A (fr)
NL (1) NL178421C (fr)
NO (1) NO150760C (fr)
NZ (1) NZ190623A (fr)
PH (1) PH17020A (fr)
PL (1) PL117515B1 (fr)
PT (1) PT69718A (fr)
SE (1) SE438333B (fr)
SG (1) SG56184G (fr)
SU (1) SU843746A3 (fr)
YU (1) YU40997B (fr)
ZA (1) ZA792729B (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57501565A (fr) * 1980-10-24 1982-09-02
US4511574A (en) * 1981-01-08 1985-04-16 Mitsui Toatsu Kagaku Kabushiki Kaisha N-(4-Phenyl-2-thiazolyl)carbamate derivatives
JPS57136579A (en) * 1981-01-21 1982-08-23 Mitsui Toatsu Chem Inc Thiazolylurea derivative, its preparation, and pharmaceutical composition containing the same
JPS57116067A (en) * 1981-01-12 1982-07-19 Sankyo Kagaku Kk Novel 8-quinolinesulfonyl derivative, its synthesis and use
EP0069154B1 (fr) * 1981-01-13 1986-10-15 Mitsui Toatsu Kagaku Kabushiki Kaisha Nouveaux composes de thiazole, procede de preparation, et composition medicinale en contenant
WO1982002386A1 (fr) * 1981-01-13 1982-07-22 Sakano Isao Derives d'aminothiazoles, procede de preparation et composition medicinale les contenant
JPS57154175A (en) * 1981-03-16 1982-09-22 Mitsui Toatsu Chem Inc 2-thiazoleamine derivative, its preparation, and drug composition comprising it
DE3227329A1 (de) * 1982-07-22 1984-01-26 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 2-n,n-disubstituierten aminothiazolen
WO1986003203A1 (fr) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Derives de thienylthiazole
FR2581063B1 (fr) * 1985-04-30 1987-07-17 Chauvin Blache Lab Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
JPS63152368A (ja) * 1986-06-03 1988-06-24 Sumitomo Pharmaceut Co Ltd 新規なアミノアゾ−ル誘導体およびその酸付加塩
JPH075579B2 (ja) * 1986-09-01 1995-01-25 吉富製薬株式会社 アミノチアゾ−ル化合物
JPH0753666B2 (ja) * 1987-09-14 1995-06-07 久光製薬株式会社 置換ジフェニルチアゾール誘導体からなる抗炎症剤
AU657257B2 (en) * 1989-08-10 1995-03-09 Auspharm International Limited Producing electrosuspensions
ATE194338T1 (de) * 1991-03-07 2000-07-15 Hisamitsu Pharmaceutical Co Diphenylthiazolderivate mit antiinflammatorischer aktivität
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
CA2195847A1 (fr) * 1994-07-27 1996-02-08 John J. Talley Thiazoles substitues destines au traitement de l'inflammation
FR2754258B1 (fr) 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
CA2397661C (fr) 2000-03-01 2012-01-03 Janssen Pharmaceutica N.V. Derives de thiazolyle 2,4-disubstitue
WO2003015777A1 (fr) * 2001-08-13 2003-02-27 Lion Bioscience Ag Composes de liaison au recepteur nucleaire nr1h4
WO2003027085A2 (fr) * 2001-09-26 2003-04-03 Bayer Pharmaceuticals Corporation Thiazoles 3-pyridyle ou 4-isoquinolinyle utilises comme inhibiteurs de lyase c17,20
WO2003059880A1 (fr) 2002-01-11 2003-07-24 Sankyo Company, Limited Derive d'amino-alcool ou derive d'acide phosphonique et composition medicamenteuse les contenant
EP1555264A1 (fr) * 2004-01-15 2005-07-20 Sireen AG Hétérocycles à cinq chaínons comme inhibiteurs de la famille des SRC proteines kinases
US7910617B2 (en) 2004-02-24 2011-03-22 Sankyo Company, Limited Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound
NZ563866A (en) 2005-05-09 2011-03-31 Achillion Pharmaceuticals Inc Thiazole compounds and methods of use
KR20080091369A (ko) 2006-01-18 2008-10-10 암젠 인크 단백질 키나제 ｂ （ｐｋｂ） 억제제로서 티아졸 화합물
JP2010533715A (ja) 2007-07-17 2010-10-28 アムジエン・インコーポレーテツド 複素環系ｐｋｂ調節剤
CA2693473A1 (fr) 2007-07-17 2009-01-22 Amgen Inc. Thiadiazoles modulateurs de l'activite de pkb
US20130143927A1 (en) * 2011-06-10 2013-06-06 Calcimedica, Inc. Compounds that modulate intracellular calcium
US20120316182A1 (en) 2011-06-10 2012-12-13 Calcimedica, Inc. Compounds that modulate intracellular calcium
WO2013059677A1 (fr) 2011-10-19 2013-04-25 Calcimedica, Inc. Composés qui modulent le calcium intracellulaire
CN110590785B (zh) * 2019-09-23 2021-02-02 武汉大学 一种氨基噻唑类化合物及其制备方法与抗肠道病毒71型的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458526A (en) * 1966-09-26 1969-07-29 Upjohn Co Certain 2-amino-4,5-bis(p-methoxyphenyl)thiazoles

Also Published As

Publication number Publication date
ATA401679A (de) 1983-05-15
NL178421B (nl) 1985-10-16
KE3459A (en) 1984-10-12
IE48426B1 (en) 1985-01-23
FR2427333B1 (fr) 1983-05-20
PL117515B1 (en) 1981-08-31
PT69718A (en) 1979-07-01
SU843746A3 (ru) 1981-06-30
SE7904798L (sv) 1979-12-03
FR2427333A1 (fr) 1979-12-28
SG56184G (en) 1985-03-08
NL178421C (nl) 1986-03-17
HU180045B (en) 1983-01-28
DK150068C (da) 1987-06-29
SE438333B (sv) 1985-04-15
JPS54160369A (en) 1979-12-19
CA1117949A (fr) 1982-02-09
IL57450A0 (en) 1979-09-30
NO150760C (no) 1984-12-12
NL7904337A (nl) 1979-12-04
FI791754A7 (fi) 1979-11-26
PL216030A1 (fr) 1980-03-10
YU128879A (en) 1982-10-31
DD144055A5 (de) 1980-09-24
BE876732A (fr) 1979-12-03
NO791831L (no) 1979-12-04
FI68820C (fi) 1985-11-11
PH17020A (en) 1984-05-11
GB2022085A (en) 1979-12-12
EG14354A (en) 1984-06-30
ES481220A1 (es) 1980-09-01
CS216927B2 (en) 1982-12-31
DE2922523C2 (de) 1982-10-21
HK66487A (en) 1987-09-25
AU4763479A (en) 1979-12-06
IL57450A (en) 1982-11-30
NZ190623A (en) 1984-07-06
IE791069L (en) 1979-12-02
MY8500318A (en) 1985-12-31
AU511242B2 (en) 1980-08-07
AR226285A1 (es) 1982-06-30
ZA792729B (en) 1981-03-25
DK177679A (da) 1979-12-03
IT7923228A0 (it) 1979-06-01
AT373248B (de) 1983-12-27
IT1121238B (it) 1986-03-26
YU40997B (en) 1986-10-31
FI68820B (fi) 1985-07-31
JPS5936988B2 (ja) 1984-09-06
NO150760B (no) 1984-09-03
DK150068B (da) 1986-12-01
GR73142B (fr) 1984-02-09
GB2022085B (en) 1983-01-12
CH639653A5 (fr) 1983-11-30
DE2922523A1 (de) 1979-12-06

Similar Documents

Publication Publication Date Title
LU81349A1 (fr) Nouveaux aminothiazoles et composition pharmaceutique les contenant
BE873500A (fr) Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant
BE867727A (fr) Nouveaux composes de phtalazine et composition pharmaceutique les contenant
BE859824A (fr) Nouveaux derives d'hydantoine et composition pharmaceutique les contenant
BE867248A (fr) Nouveaux isomeres dextrogyres de spiro-hydantoines asymetriques et compositions pharmaceutiques les contenant
FR2430410B1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
BE877597A (fr) Metaphenylenediamines et compositions tinctoriales les contenant
BE892805A (fr) Cycloalcanes substitues et compositions pharmaceutiques les contenant
BE880065A (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
LU78330A1 (fr) Procede de preparation de nouveaux derives d'hydantoine et de composition pharmaceutique les contenant
BE870402A (fr) Nouveaux phenols a substituant hydroxyalkyle ou oxoalkyle et composition pharmaceutique les contenant
BE876042A (fr) Nouvelles 4-(quinoleinylaminobenzoyl) piperidines et composition pharmaceutique les contenant
BE879472A (fr) Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines
FR2446819B1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
BE885389A (fr) Composes penam acetoxymethyles et composition pharmaceutique les contenant
FR2331339A1 (fr) Nouveaux composes heterocycliques et composition pharmaceutique les contenant
FR2352790A1 (fr) Nouveaux benzamides n-(acyl)-p-amino-n'-monosubstitues et composition pharmaceutique les contenant
EP0018417A4 (fr) Nouveaux derives de piperidine et compositions pharmaceutiques les contenant.
FR2329281A1 (fr) Nouveaux 6,8-dioxamorphinanes n-substitues et composition pharmaceutique les contenant
BE832725A (fr) Nouveaux composes meterocycliques et composition pharmaceutique les contenant
BE815584A (fr) Nouveaux 3-alkyl-9-aminoalkyl-1,2,3,4-tetra-hydrocarbazoles et composition pharmaceutique les contenant
BE884530A (fr) Nouveaux hexahydro-trans-pyrido-indoles et composition pharmaceutique les contenant
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
BE883859A (fr) Nouveaux pyridylaminotriazoles et composition pharmaceutique les contenant
FR2351954A1 (fr) Nouveaux polypeptides et composition pharmaceutique les contenant